InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Uger Robert, Directeur Scientifique. Officer active across 1 companies, notably Trillium Therapeutics Inc.. Cumulatively, 6 filings have been logged. The latest transaction was filed on 7 July 2021 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€9403,646 shares@ €0.257733.2% of flow
Common Shares
SEC:0001062993-21-006419·
€9403,646 shares@ €0.257716.6% of flow
Common Shares
SEC:0001062993-21-006419:0·
€9423,646 shares@ €0.258333.3% of flow
Common Shares
SEC:0001062993-21-005487·
€9423,646 shares@ €0.258316.7% of flow
Common Shares
SEC:0001062993-21-005487:0·
€9463,646 shares@ €0.259433.4% of flow
Common Shares
SEC:0001062993-21-004390·
€9463,646 shares@ €0.259416.7% of flow
Common Shares
SEC:0001062993-21-004390:0·
6 of 6 declarations
About Uger Robert
Robert Uger is the Chief Scientific Officer at Trillium Therapeutics Inc. He oversees the company's research and development initiatives. His role is essential in ensuring scientific innovation and the development of new treatments.
